24 Jan 2019
Looking for CMO to manufacture Physostigmine salicylate USP on regular basis [ENA03218]
A leading global pharmaceutical company in the United States is looking for US FDA approved manufacturers to produce Physostigmine salicylate USP con contact basis.
strategy@dishmangroup.com
kindly, contact for CMO of API from US FDA approved site.
15:48, 29 Jan 2019